OPXBIO uses its proprietary, leading EDGE™ (Efficiency Directed Genome Engineering) technology to manufacture renewable bio-based chemicals and fuels that are lower cost, higher return and more sustainable than existing petroleum-based products. In addition to DBL Partners, investors include:X/Seed Capital, USRG, Mohr Davidow, Braemar Energy Ventures and Wolfensohn & Co.
Location: United States, Colorado, Boulder
Employees: 11-50
Total raised: $36.5M
Founded date: 2007
Investors 2
| Date | Name | Website |
| - | DBL Partne... | dbl.vc |
| 08.05.2021 | DBL Partne... | dblpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.07.2011 | Series C | $36.5M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 08.07.2011 | OPX Biotechnologies Raises $36.5M in first closing of Series... | OPX Biotechnologies Inc., a Boulder, CO-based manufacturer of renewable bio-based chemicals and fuel... | finsmes.co... |